Home
NICE Guidance
Published Guidance

Regorafenib for previously treated advanced hepatocellular carcinoma

Technology appraisal guidance [TA514] Published: 21 March 2018

Guidance

This guidance has been updated and replaced by NICE technology appraisal guidance 555.